AzTrials
AzTrials

Healthy DietDIETENCT04347213

The Link Between Diets and Health Indicators

An observational study of Healthy Diet and Microbiota, run by University of Primorska at 1 site in Slovenia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The cohort study investigates the effect of different dietary intake among omnivorous, vegan, vegetarian and low-carb diets on health parameters and on long-term overall health. The participants blood parameters, dietary intake, gut microbiota composition, body mass and composition, resting energy expenditure… Read more about this study

Who is it for?
Ages 20 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Diet, Microbiota
What is being tested?
Regular lifestyle in different circumstances
How many people
200 participants
Where
1 siteSlovenia
Study dates
18 Jan 2020to 15 Jan 2023
How long will I take part?
10 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Healthy individuals with stable body mass with specific eating patterns: omnivores, vegetarians, vegan, low carb high fat.

Who may be able to join

  • 18,5 < BMI < 30 kg/m2
  • asymptomatic for any disease
  • medication free
  • same pattern of eating in the last 3 months
  • stable body mass in the last 3 months

Who cannot join

  • BMI < 18,5 and > 30 kg/m2
  • presence of any chronic disease
  • taking any medications
  • changed eating pattern in the last 3 months
  • unstable body mass in the last 3 months
  • taking antibiotics in the last 3 months

Trial locations and contacts

1 site in 1 country.

Slovenia1 site
  • University of Primorska, Faculty of Health Sciences

    Izola, SI-6310

Other trials in Slovenia

About this study

Official title: The Link Between Omnivorous, Vegan, Vegetarian, Low Carb Diets and Health Indicators in Healthy Subjects With Normal Weight

The cohort study investigates the effect of different dietary intake among omnivorous, vegan, vegetarian and low-carb diets on health parameters and on long-term overall health. The participants blood parameters, dietary intake, gut microbiota composition, body mass and composition, resting energy expenditure, lifestyle factors and psychological factors will be determined and measured.

Read the detailed description

Vegetarian and vegan diets have been shown to have health benefits on preventing cardiovascular diseases, type 2 diabetes and cancer. They are both gaining popularity in public. Ketogenic diet has also been very popular, especially due to its effect on weight loss and blood glucose parameters. To our knowledge there, are no studies that compare long-term effects of all three diets and omnivorous diets with regards to health parameters and gut microbiota composition.

The aim of the proposed study is to investigate the link between different diets and health parameters, such as parameters related to longevity, inflammation, stress and gut microbiota composition. The study is designed to compare different diets and their relationship with the body as a whole.

Being tested
Regular lifestyle in different circumstances
Keywords
diet, gut microbiota, longevity, inflammation, health
Medical subject headings
Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Regular lifestyle in different circumstancesBehavioural

    Participants' lifestyle will be followed over the years.

Study groups in NCT04347213
Study groupRoleWhat they receive
omnivorsParticipants who habitually consume all food groups in their diet.
Receives: Behavioral: Regular lifestyle in different circumstances
vegetarianParticipants who habitually avoid meat in their diet.
Receives: Behavioral: Regular lifestyle in different circumstances
veganParticipants who habitually avoid all animal source food in their diet.
Receives: Behavioral: Regular lifestyle in different circumstances
low-carbohydrate high-fat dietParticipants who habitually avoid carbohydrate in their diet.
Receives: Behavioral: Regular lifestyle in different circumstances

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in systemic inflammation

    CRP [mg/L] will be measured as a marker of inflammation.

    Measured: Change from baseline at 5 years.

  2. Changes in serum total antioxidative capacity

    Total antioxidative capacity of serum will be measured with Photochem instrument and expressed as nanomole equivalents of ascorbic acid per microliter of serum.

    Measured: Change from baseline at 5 years.

Secondary outcomes (10)
  1. Changes in macronutrient intake

    Macronutrient intake will be measured with validated FFQ and 3-day food diary and analysed with softwares OPEN and Prodi. Macronutrient intake will be expressed as part of daily energy intake.

    Measured: Change from baseline at 5 years.

  2. Changes in micronutrient intake

    Micronutrient intake will be measured with validated FFQ and 3-day food diary and analysed with softwares OPEN and Prodi. Micronutrient intake will be expressed as mg per day.

    Measured: Change from baseline at 5 years.

  3. Changes in gut microbiota composition

    Microbial composition of stool will be determined with microbial DNA isolation and identification.

    Measured: Change from baseline at 5 years.

  4. Changes in body composition

    Fat free body mass will be measured with bioelectrical impedance analysis and expressed in kg.

    Measured: Change from baseline at 5 years.

  5. Changes in resting metabolic rate

    Resting metabolic rate will be determined with indirect calorimeter and expressed in kJ/day.

    Measured: Change from baseline at 5 years.

  6. Changes in lifestyle factors

    Will be assessed with a questionnaire.

    Measured: Change from baseline at 5 years.

  7. Changes in anxiety

    Will be assessed by state-trait anxiety inventory. The STAIX-1 contains 20 items, which are scored on a 4-pointscale with subscale scores ranging from 20 to 80, with higherscores indicating higher anxiety.

    Measured: Change from baseline at 5 years.

  8. Changes in body satisfaction

    Will be assessed by the body dissatisfaction subscale from the Eating Disorders Inventory-2. Responses will be rated on a 5-point Likert scale from 0 (never) to 4 (always).

    Measured: Change from baseline at 5 years.

  9. Changes in grip strength

    Will be measured with a hand dynamometer.

    Measured: Change from baseline at 5 years.

  10. Changes in autophagy

    Autophagy will be measured by autophagy-related mRNA gene expression evaluation.

    Measured: Change from baseline at 5 years.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2020
  2. Study start18 Jan 2020
  3. Primary completion15 Jan 2022
  4. Study completion15 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
200 participants (actual)
Target duration
10 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT04347213
Sponsor's protocol ID
DIETE
Acronym
DIETE
Status last verified
Aug 2023
First submitted
3 Apr 2020
Last updated
8 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Paoli A, Mancin L, Bianco A, Thomas E, Mota JF, Piccini F. Ketogenic Diet and Microbiota: Friends or Enemies? Genes (Basel). 2019 Jul 15;10(7):534. doi: 10.3390/genes10070534.

    PubMed 31311141
  • Rocha JP, Laster J, Parag B, Shah NU. Multiple Health Benefits and Minimal Risks Associated with Vegetarian Diets. Curr Nutr Rep. 2019 Dec;8(4):374-381. doi: 10.1007/s13668-019-00298-w.

    PubMed 31705483
  • Sakkas H, Bozidis P, Touzios C, Kolios D, Athanasiou G, Athanasopoulou E, Gerou I, Gartzonika C. Nutritional Status and the Influence of the Vegan Diet on the Gut Microbiota and Human Health. Medicina (Kaunas). 2020 Feb 22;56(2):88. doi: 10.3390/medicina56020088.

    PubMed 32098430
  • Satija A, Bhupathiraju SN, Rimm EB, Spiegelman D, Chiuve SE, Borgi L, Willett WC, Manson JE, Sun Q, Hu FB. Plant-Based Dietary Patterns and Incidence of Type 2 Diabetes in US Men and Women: Results from Three Prospective Cohort Studies. PLoS Med. 2016 Jun 14;13(6):e1002039. doi: 10.1371/journal.pmed.1002039. eCollection 2016 Jun.

    PubMed 27299701
  • Kenig S, Petelin A, Poklar Vatovec T, Mohorko N, Jenko-Praznikar Z. Assessment of micronutrients in a 12-wk ketogenic diet in obese adults. Nutrition. 2019 Nov-Dec;67-68:110522. doi: 10.1016/j.nut.2019.06.003. Epub 2019 Jun 14.

    PubMed 31445313
  • Mohorko N, Petelin A, Jurdana M, Biolo G, Jenko-Praznikar Z. Elevated serum levels of cysteine and tyrosine: early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome. Biomed Res Int. 2015;2015:418681. doi: 10.1155/2015/418681. Epub 2015 Mar 4.

    PubMed 25821801
  • Mohorko N, Jenko-Praznika Z, Petelin A. Leucine and lysine intakes are highly associated with serum adiponectin levels in asymptomatic adults. Minerva Endocrinol. 2016 Sep;41(3):302-13. Epub 2015 Feb 13.

    PubMed 25677829
  • Cernelic-Bizjak M, Jenko-Praznikar Z. Body dissatisfaction predicts inflammatory status in asymptomatic healthy individuals. J Health Psychol. 2018 Jan;23(1):25-35. doi: 10.1177/1359105316672923. Epub 2016 Oct 19.

    PubMed 28810361
  • Bizjak M, Jenko-Praznikar Z, Korousic Seljak B. Development and validation of an electronic FFQ to assess food intake in the Slovene population. Public Health Nutr. 2014 Aug;17(8):1729-37. doi: 10.1017/S1368980013002577. Epub 2013 Oct 8.

    PubMed 24103359
  • Jenko-Praznikar Z, Petelin A, Jurdana M, Ziberna L. Serum bilirubin levels are lower in overweight asymptomatic middle-aged adults: an early indicator of metabolic syndrome? Metabolism. 2013 Jul;62(7):976-85. doi: 10.1016/j.metabol.2013.01.011. Epub 2013 Feb 13.

    PubMed 23414908
  • Bogataj Jontez N, Kenig S, Sik Novak K, Petelin A, Jenko Praznikar Z, Mohorko N. Habitual low carbohydrate high fat diet compared with omnivorous, vegan, and vegetarian diets. Front Nutr. 2023 Apr 13;10:1106153. doi: 10.3389/fnut.2023.1106153. eCollection 2023.

    PubMed 37125046
  • Sik Novak K, Bogataj Jontez N, Kenig S, Hladnik M, Baruca Arbeiter A, Bandelj D, Cernelic Bizjak M, Petelin A, Mohorko N, Jenko Praznikar Z. The effect of COVID-19 lockdown on mental health, gut microbiota composition and serum cortisol levels. Stress. 2022 Jan;25(1):246-257. doi: 10.1080/10253890.2022.2082280.

    PubMed 35713539

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Diet and Microbiota, run by University of Primorska at 1 site in Slovenia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Slovenia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in systemic inflammation (time frame: Change from baseline at 5 years.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04347213, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in